Benzinga | Feb 5, 2021 07:34AM EST

Meridian Bioscience Q1 EPS $0.65 Beats $0.42 Estimate, Sales $92.90M Beat $83.89M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.42 by 54.76 percent. This is a 550 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $92.90 million which beat the analyst consensus estimate of $83.89 million by 10.74 percent. This is a 95.90 percent increase over sales of $47.42 million the same period last year.